Related Experiment Videos
Bone marrow transplantation for Diamond-Blackfan anemia
H Mugishima1, R P Gale, P A Rowlings
1International Bone Marrow Transplant Registry, Health Policy Institute, Medical College of Wisconsin, Milwaukee 53226, USA.
Bone Marrow Transplantation
|January 1, 1995
Summary
Bone marrow transplants offer a potential cure for steroid-resistant Diamond-Blackfan anemia (DBA). HLA-identical sibling transplants showed promising survival rates in children with DBA.
Area of Science:
- Hematology
- Pediatric Hematology
- Transplantation Immunology
Background:
- Diamond-Blackfan anemia (DBA) is a rare inherited bone marrow failure syndrome.
- Most DBA cases respond to corticosteroids, but over 20% are steroid-resistant.
- Alternative treatments are needed for steroid-resistant DBA.
Purpose of the Study:
- To evaluate the efficacy and outcomes of bone marrow transplantation in children with Diamond-Blackfan anemia.
- To assess the impact of donor type on transplant success in DBA patients.
Main Methods:
- Retrospective analysis of 10 children with DBA who underwent bone marrow transplantation.
- Data collected from the International Bone Marrow Transplant Registry.
- Analysis included donor type (HLA-identical sibling, maternal, unrelated) and patient survival.
Main Results:
- Six out of eight recipients of HLA-identical sibling transplants survived long-term (5-87 months) with no evidence of DBA and excellent performance scores.
- Two recipients of non-HLA-identical sibling transplants died within two weeks.
- The actuarial 2-year survival probability for HLA-identical sibling transplants was 72%.
Conclusions:
- Bone marrow transplantation, particularly from HLA-identical siblings, can be a curative option for children with steroid-resistant Diamond-Blackfan anemia.
- HLA-identical sibling donors are associated with significantly better outcomes compared to non-HLA-identical donors.
- Further research into optimizing transplant protocols for DBA is warranted.